Metrikler
Yayın
35
Açık Erişim
8
BM Sürdürülebilir Kalkınma Amaçları
Eğitim Bilgileri
2012 - Devam Ediyor
2012 - Devam EdiyorDoktora
Hacettepe Üniversitesi, Tıp Fakültesi, İç Hastalıkları , Türkiye
Yabancı Diller
B2 Orta Üstü
B2 Orta Üstüİngilizce
Akademi Dışı Deneyim
2017 - 2018
2017 - 2018UZMAN DOKTOR
SAĞLIK BAKANLIĞI-Dr. Abdurrahman Yurtaslan Ankara Onkoloji Eğitim ve Araştırma Hastanesi, UZMAN DOKTOR
2017 - 2017
2017 - 2017UZMAN DOKTOR
SAĞLIK BAKANLIĞI-Sorgun Devlet Hastanesi, UZMAN DOKTOR
Makaleler
Tümü (27)
SCI-E, SSCI, AHCI (21)
SCI-E, SSCI, AHCI, ESCI (25)
ESCI (4)
Scopus (25)
TRDizin (9)
Diğer Yayınlar (1)
2023
20231. Splenic Gaucheroma Leading to Incidental Diagnosis of Gaucher Disease in a 46-Year-Old Man with a Rare GBA Mutation: A Case Report
Erdal İ., YILDIZ Y., ÖNAL G., AKTEPE O. H., Düzgün S. A., Sağlam A., et al.
Endocrine, Metabolic and Immune Disorders - Drug Targets
, cilt.23, sa.2, ss.230-234, 2023 (SCI-Expanded, Scopus)
2022
20222. Lesson learned from the pandemic: Isolation and hygiene measures for COVID-19 could reduce the nosocomial infection rates in oncology wards
GÜVEN D. C., EROĞLU İ., Ismayilov R., ULUSOYDAN E., AKTEPE O. H., TELLİ DİZMAN G., et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE
, cilt.28, sa.8, ss.1807-1811, 2022 (SCI-Expanded, Scopus)
2022
20223. Prognosis of Liposarcoma Patients in Modern ERA: Single-Center Experience
DEMİR M., Guven D., AKTAŞ B. Y., GÜNER G., AKTEPE O. H., TABAN H., et al.
SOUTH ASIAN JOURNAL OF CANCER
, cilt.11, ss.287-292, 2022 (ESCI, Scopus)
2022
20224. Blood Based Biomarkers as Predictive Factors for Hyperprogressive Disease
YILDIRIM H. Ç., GÜVEN D. C., AKTEPE O. H., TABAN H., YILMAZ F., YAŞAR S., et al.
JOURNAL OF CLINICAL MEDICINE
, cilt.11, sa.17, 2022 (SCI-Expanded, Scopus)
2022
20225. THSD7A expression: a novel immunohistochemical determinant in predicting overall survival of metastatic renal cell carcinoma treated with targeted therapy
Aktepe O. H., Gundogdu F., Kosemehmetoglu K., Yeter H. H., Aksoy S., Guven D. C., et al.
IRISH JOURNAL OF MEDICAL SCIENCE
, cilt.191, sa.4, ss.1561-1567, 2022 (SCI-Expanded, Scopus)
2022
20226. The Association between Early Changes in Neutrophil-Lymphocyte Ratio and Survival in Patients Treated with Immunotherapy
GÜVEN D. C., ŞAHİN T. K., Erul E., ÇAKIR İ. Y., ÜÇGÜL E., YILDIRIM H. Ç., et al.
JOURNAL OF CLINICAL MEDICINE
, cilt.11, sa.15, 2022 (SCI-Expanded, Scopus)
2022
20227. The burden of polypharmacy and drug-drug interactions in older cancer patients treated with immunotherapy
GÜVEN D. C., KAVGACI G., AKTEPE O. H., YILDIRIM H. H., ŞAHİN T. K., AKSOY S., et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE
, cilt.28, sa.4, ss.785-793, 2022 (SCI-Expanded, Scopus)
2022
20228. Everolimus and/or Nivolumab-Associated Cytomegalovirus Colitis in a Patient with Metastatic Renal Cell Carcinoma
Ismayilov R., AKTEPE O. H., Sardarova K., LEBLEBİCİ C. B., ERMAN M.
EURASIAN JOURNAL OF MEDICINE
, cilt.54, sa.1, ss.77-79, 2022 (ESCI, Scopus, TRDizin)
2022
20229. The use of fulvestrant before chemotherapy improves survival in hormone-positive breast cancer: a real-life study
GÜVEN D. C., YILDIRIM H. Ç., ERUL E., ŞAHİN T. K., ÇAKIR İ. Y., AKTEPE O. H., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.52, sa.5, ss.1551-1558, 2022 (SCI-Expanded, Scopus, TRDizin)
2022
202210. Differences between Hyperprogressive Disease and Progressive Disease in Patients Receiving Immunotherapy
YILDIRIM H. Ç., GÜVEN D. C., AKTEPE O. H., TABAN H., YILMAZ F., YAŞAR S., et al.
EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY
, cilt.6, sa.1, ss.59-63, 2022 (ESCI, TRDizin)
2021
202111. Correlation Between THSD7A Expression and Tumor Characteristics of Azoxymethane-Induced Colon Cancer Model in Rats
AKTEPE O. H., ŞAHİN T. K., GÜNER G., GÜVEN D. C., YETER H. H., KURTULAN O., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.32, sa.12, ss.1049-1056, 2021 (SCI-Expanded, Scopus, TRDizin)
2021
202112. A systematic review and meta-analysis of the association between circulating tumor DNA (ctDNA) and prognosis in pancreatic cancer
GÜVEN D. C., ŞAHİN T. K., YILDIRIM H. Ç., AKTEPE O. H., DİZDAR Ö., YALÇIN Ş.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
, cilt.168, 2021 (SCI-Expanded, Scopus)
2021
202113. The Predictive Value of Red Blood Cell Distribution Width for Survival Outcomes of Metastatic Renal Cell Carcinoma Patients Treated with Targeted Therapy
AKTEPE O. H., GÜVEN D. C., ŞAHİN T. K., YILDIRIM H. Ç., ÇELİKTEN B., Yeter H. H., et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
, cilt.73, sa.10, ss.1957-1963, 2021 (SCI-Expanded, Scopus)
2021
202114. Newly diagnosed cancer and the COVID-19 pandemic: tumour stage migration and higher early mortality
GÜVEN D. C., ŞAHİN T. K., YILDIRIM H. Ç., ÇEŞMECİ E., Incesu F. G. G., TAHILLIOĞLU Y., et al.
BMJ SUPPORTIVE & PALLIATIVE CARE
, 2021 (SCI-Expanded, Scopus)
2021
202115. Lower prognostic nutritional index is associated with poorer survival in patients receiving immune-checkpoint inhibitors
GÜVEN D. C., AKTEPE O. H., TABAN H., AKTAŞ B. Y., GÜNER G., YILDIRIM H. H., et al.
BIOMARKERS IN MEDICINE
, cilt.15, sa.13, ss.1123-1130, 2021 (SCI-Expanded, Scopus)
2021
202116. Poorer baseline performance status is associated with increased thromboembolism risk in metastatic cancer patients treated with immunotherapy
GÜVEN D. C., AKSUN M. S., ŞAHİN T. K., AKTEPE O. H., YILDIRIM H. Ç., TABAN H., et al.
SUPPORTIVE CARE IN CANCER
, cilt.29, sa.9, ss.5417-5423, 2021 (SCI-Expanded, Scopus)
2021
202117. Evaluation of emergency departments visits in patients treated with immune checkpoint inhibitors
GÜVEN D. C., ŞAHİN T. K., AKSUN M. S., TABAN H., AKTEPE O. H., METİN AKSU N., et al.
SUPPORTIVE CARE IN CANCER
, cilt.29, sa.4, ss.2029-2035, 2021 (SCI-Expanded, Scopus)
2021
202118. Impact of albumin to globulin ratio on survival outcomes of patients with metastatic renal cell carcinoma
AKTEPE O. H., GÜNER G., GÜVEN D. C., TABAN H., YILDIRIM H. Ç., ŞAHİN T. K., et al.
TURKISH JOURNAL OF UROLOGY
, cilt.47, sa.2, ss.113-119, 2021 (ESCI, Scopus, TRDizin)
2021
202119. Lycopene sensitizes the cervical cancer cells to cisplatin via targeting nuclear factor- kappa B (NF-κB) pathway
Aktepe O. H., Şahin T. K., Güner G., Arik Z., Yalçin Ş.
Turkish journal of medical sciences
, cilt.51, ss.368-374, 2021 (SCI-Expanded, Scopus, TRDizin)
2021
202120. The platelet to lymphocyte ratio predicts overall survival better than the neutrophil to lymphocyte ratio in metastatic renal cell carcinoma.
Aktepe O. H., GÜner G., GÜven D. C., Şahİn T. K., ArdiÇ F. S., YÜce D., et al.
Turkish journal of medical sciences
, cilt.51, ss.757-765, 2021 (SCI-Expanded, Scopus, TRDizin)
2021
202121. Survival Outcomes of Patients in Advanced Non-Clear Renal Cell Carcinoma Treated with Pazopanib: A Retrospective Single Institution Experience
AKTEPE O. H., ERMAN M.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.31, sa.3, ss.170-177, 2021 (SCI-Expanded, Scopus, TRDizin)
2020
202022. Defining the Optimal Regimen for Stage III Colon Cancer: Concerns with Study Design
GÜVEN D. C., GÜNER G., AKTAŞ B. Y., AKTEPE O. H., TABAN H., ARIK Z.
CLINICAL COLORECTAL CANCER
, cilt.19, sa.3, 2020 (SCI-Expanded, Scopus)
2020
202023. Anti-prostate cancer activity of a nanoformulation of the spleen tyrosine kinase (SYK) inhibitor C61
ŞAHİN T. K., AKTEPE O. H., Uckun F. M., YALÇIN Ş.
ANTI-CANCER DRUGS
, cilt.31, sa.6, ss.609-616, 2020 (SCI-Expanded, Scopus)
2020
202024. Complete responses to two different anti-PD1 agents in a metastatic melanoma patient
KILIÇKAP S., GÜVEN D. C., AKTEPE O. H., AKTAŞ B. Y., DİZDAR Ö.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE
, cilt.26, sa.2, ss.496-499, 2020 (SCI-Expanded, Scopus)
2020
202025. Does primary tumor localization has prognostic importance in seminoma patients?: Turkish Oncology Group Study
Yildiz B., Kucukarda A., Gokyer A., Demiray A. G., PAYDAŞ S., Aral I. P., et al.
JOURNAL OF BUON
, cilt.25, sa.2, ss.1130-1135, 2020 (SCI-Expanded, Scopus)
2018
201826. Sequential vitamin D and parathyroid hormone measurement in patients with septic shock: Could they be prognostic marker in septic shock
YETER H. H., AKTEPE O. H., TOPELİ İSKİT A.
Experimental Biomedical Research , cilt.1, sa.3, ss.90-102, 2018 (Hakemli Dergi)
2016
201627. Urinary Tract Infection Caused by Raoutella Ornithinolytica in a Patient With Bladder Cancer
YETER H. H., AKTEPE O. H.
Türkiye Klinikleri Journal of Medical Research , cilt.24, sa.3, ss.216-218, 2016 (TRDizin)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2016
20161. Is obesity paradox real or not? The role of leptin in septic shock patients
AKTEPE O. H., KARA A., YETER H. H., TOPELİ İSKİT A.
European society of intensive medicine (ESICM 2016), 1 - 05 Ekim 2016, cilt.4, (Özet Bildiri)
2016
20162. Akut Böbrek Hasarı Gelişim Zamanının Kritik Hastalarda Mortalite Üzerine Etkisi: Yoğun bakımda kazanılmış akut böbrek hasarı yeni bir terminoloji mi?
YETER H. H., KARA A., EYÜPOĞLU N. D., ÇELEBİ F., AKTEPE O. H., AKÇAY Ö. F., et al.
18. ULUSAL HİPERTANSİYON VE BÖBREK HASTALIKLARI KONGRESİ, Girne, Kıbrıs (Kktc), 12 - 15 Mayıs 2016, (Özet Bildiri)